FindTrial
Sign In

To study the changes in ECG in Diabetes Mellitus as an indicator of heart disease.

To study the relationship of QTc prolongation in diagnosis of Cardiac Autonomic Neuropathy in Diabetes Mellitus. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/11/098212
Enrollment
666
Registered
2025-11-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I256- Silent myocardial ischemia

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Dr Gopinath Gorige
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All known cases of Diabetes Mellitus.

Exclusion criteria

Exclusion criteria: Non Diabetic On drugs than are known to cause QTc prolongation (ex antiarrythmic drugs, antipsychotic drugs, etc.) Known case of Hypothyroidism Known case of Chronic Kidney Disease (Hypocalcemia, Hypomagnesemia, Hypokalemia) IC Bleed, Acute Myocardial Infarction

Design outcomes

Primary

MeasureTime frame
To study the relationship of Qtc prolongation in diagnosis of Cardiac Autonomic Neuropathy in Diabetes Mellitus Timepoint: 2 years—

Secondary

MeasureTime frame
To study the relationship between Qtc prolongation with other complications of Diabetes MellitusTimepoint: 2 years—

Countries

India

Contacts

Public ContactDr Prachi sankhe

Dy patil university school of medicine

prachi.sankhe@dypatil.edu9833500598

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026